To determine whether long-term semaglutide use is right for you, talk with your doctor
The greater magnitudes of bodyweight reduction seen in this trial, as well as the improvements in cardiovascular risk factors and glucose control, can have beneficial effects on health goals in clinical practice. In the STEP UP T2D trial, a higher semaglutide dose resulted in an average bodyweight reduction of 13.2%, compared to 10.4% for the standard dose and 3.9% for the placebo
Know what to expect when you switch Switching from a compounded to a brand-name GLP-1 may come with a short adjustment period
The majority of procedures performed were primary procedures ( n = 114) with gastric bypass being the most commonly performed revisional procedure ( n = 26/45)
Possible Side Effects of Semaglutide and Considerations Common Side Effects: While semaglutide is generally well-tolerated, some individuals may experience side effects, such as nausea, diarrhea, constipation, and in rare cases, more serious gastrointestinal issues